Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences' JARIT Surgical Instruments Launches Redmond/R&B Instruments at 2004 AORN Congress
Integra LifeSciences' JARIT Surgical Instruments Launches Redmond/R&B Instruments at 2004 AORN Congress PLAINSBORO, N.J., March 23, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that JARIT® Surgical Instruments launched the Redmond/R&B Surgical
View HTML
Toggle Summary Integra LifeSciences' JARIT® Surgical Instruments Awarded Surgical Instrument Agreement by HealthTrust Purchasing Group, L.P.
Integra LifeSciences' JARIT® Surgical Instruments Awarded Surgical Instrument Agreement by HealthTrust Purchasing Group, L.P. Plainsboro, New Jersey, November 13, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that JARIT® Surgical Instruments has been
View HTML
Toggle Summary Integra LifeSciences' Miltex Business Acquires DenLite Product Line from Welch Allyn
Integra LifeSciences' Miltex Business Acquires DenLite Product Line from Welch Allyn PLAINSBORO, N.J., Jan. 3, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its Miltex Dental business has acquired the assets of the DenLite illuminated mirror
View HTML
Toggle Summary Integra LifeSciences' Proposed Acquisition of the Radionics Division of Tyco Healthcare Group, L.P. Clears Antitrust Review
Integra LifeSciences' Proposed Acquisition of the Radionics Division of Tyco Healthcare Group, L.P. Clears Antitrust Review PLAINSBORO, N.J., Dec. 12, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the waiting period under the Hart-Scott-Rodino
View HTML
Toggle Summary Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter
Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter PLAINSBORO, N.J., April 9, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that
View HTML
Toggle Summary Integra NeuroSciences Announces FDA Clearance to Market the Selector® Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures
Integra NeuroSciences Announces FDA Clearance to Market the Selector® Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has
View HTML
Toggle Summary Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets
Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has launched the Camino® Single
View HTML
Toggle Summary Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting
Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting PLAINSBORO, N.J., Oct 1, 2001 (BUSINESS WIRE) -- Integra NeuroSciences, the neurosurgical device division of Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced that it is
View HTML
Toggle Summary Integra NeuroSciences Awarded Neurosurgery Agreement By Premier, Inc.
Integra NeuroSciences Awarded Neurosurgery Agreement By Premier, Inc. Neurosurgical Products Offered at Substantial Savings Plainsboro, NJ / January 2, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported that it has been selected as a national supplier for Premier's
View HTML
Toggle Summary Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent
Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent PLAINSBORO, N.J., Jan 14, 2002 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing Helitene® Absorbable
View HTML